Contract Manufacturing Organizations
•57 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (57)
%
| Company | Market Cap | Price |
|---|---|---|
|
Purification & Filtration and fill-finish site acquisitions indicate active Contract Manufacturing Organization capabilities.
|
$198.11B |
$524.80
-1.88%
|
|
Pfizer operates a contract manufacturing arm (Pfizer CentreOne) providing pharma manufacturing services.
|
$137.19B |
$24.09
-0.15%
|
|
BIOVECTRA and NASD CDMO capabilities position Agilent as a contract manufacturing organization.
|
$40.00B |
$140.11
-0.12%
|
|
Cardinal Health operates BioPharma Solutions, a contract manufacturing organization that provides outsourced pharmaceutical manufacturing services.
|
$37.44B |
$156.88
-0.61%
|
|
Contract Manufacturing Organizations captures the CDMO-like manufacturing services via the Pharmaceutics International acquisition.
|
$20.82B |
$193.99
-5.75%
|
|
Contract-Manufactured Products segment indicates CDMO-style design, manufacture, and assembly of complex devices.
|
$18.81B |
$261.77
-1.19%
|
|
Peptide manufacturing capability aligns with contract manufacturing of biologics/pharma, expanding vertical integration.
|
$12.08B |
$53.95
-7.45%
|
|
The PSAI/CDMO business provides contract manufacturing services and API/drug substance production in-house.
|
$11.96B |
$14.34
+1.63%
|
|
Mod3 Pharma's clinical trial manufacturing capabilities expand Aptar Pharma into Contract Manufacturing Organizations (CDMO) services.
|
$8.65B |
$130.93
-0.01%
|
|
Manufacturing Solutions and synergy with CDMO operations indicate CRL provides contract development and manufacturing services.
|
$7.38B |
$146.07
-2.26%
|
|
Integer is a contract development and manufacturing organization for medical devices, providing outsourced development and manufacturing services to OEMs.
|
$3.53B |
$101.05
-1.93%
|
|
Acquisition of RLS Radiopharmacies to establish U.S. production/distribution aligns with Contract Manufacturing Organizations.
|
$3.35B |
$10.00
|
|
Potential Contract Manufacturing Organization (CMO) capabilities via GLP-1 collaboration and future offerings.
|
$3.12B |
$9.97
-3.11%
|
|
Contract Manufacturing Organizations reflects ANI's contract manufacturing services and U.S. production capabilities that support supply reliability.
|
$1.99B |
$90.17
-1.51%
|
|
The company provides manufacturing services (Monoplant capacity sharing) to third parties, consistent with 'Contract Manufacturing Organizations'.
|
$1.53B |
$11.35
+0.44%
|
|
Just Evotec Biologics operates as a biologics Contract Manufacturing Organization (CDMO).
|
$1.38B |
$7.28
|
|
Embecta provides contract manufacturing services and co-packaging partnerships with partners.
|
$834.00M |
$14.47
+1.47%
|
|
KE is a contract manufacturer providing outsourced electronics and medical device manufacturing services.
|
$729.22M |
$29.91
+1.08%
|
|
SunOpta operates as a co-manufacturer and private-label partner for brands and retailers, aligning with Contract Manufacturing Organizations.
|
$691.15M |
$5.88
+0.51%
|
|
Contract manufacturing capabilities and third-party supply to customers indicate contract manufacturing services.
|
$630.06M |
$7.84
-11.11%
|
|
MGPI's Distilling Solutions segment operates as a contract manufacturer for distillates and aging, i.e., contract manufacturing services.
|
$507.12M |
$23.84
-2.65%
|
|
The company highlights its specialized manufacturing network and past asset divestitures, indicating substantial Contract Manufacturing Organization capabilities for pharma/biotech products.
|
$483.62M |
$8.91
+0.45%
|
|
Solésence provides contract development and manufacturing services for beauty and personal care brands (CDMO).
|
$249.57M |
$3.56
-1.11%
|
|
Lifecore operates as a pure-play CDMO focused on sterile injectable manufacturing (contract manufacturing for pharma/biotech).
|
$240.66M |
$6.50
-2.40%
|
|
Management discusses securing CDMO partnerships and GMP-grade material production, pointing to contract manufacturing as a current/future capability.
|
$214.57M |
$2.59
-7.50%
|
|
Rocky Brands provides Contract Manufacturing services, including third-party production and Navy orders.
|
$198.32M |
$26.58
-4.87%
|
|
CDMO operations include contract manufacturing of plant-derived compounds, fitting Contract Manufacturing Organizations.
|
$191.30M |
$11.04
-8.08%
|
|
The company manufactures drug substances for partners (e.g., Elelyso supply to Pfizer and other collaborations), indicating contract manufacturing capabilities.
|
$188.17M |
$2.36
+5.36%
|
|
Provides ODM/contract manufacturing services for nicotine vaping devices from its Malaysia facility.
|
$125.72M |
$2.20
-7.95%
|
|
Development of a GMP-compliant manufacturing factory through Nika Europe signals in-house pharmaceutical production capacity, consistent with contract manufacturing capabilities.
|
$109.82M |
$0.32
|
|
Operates a commercial-scale manufacturing facility and provides contract manufacturing services.
|
$106.62M |
$1.69
-4.52%
|
|
Pocono Pharmaceuticals' contract manufacturing capabilities, including production of topical/transdermal products, fit the Contract Manufacturing Organization (CMO) category.
|
$83.77M |
$7.51
-4.21%
|
|
Contract manufacturing services for OEMs, including electronics, aligning with outsourced manufacturing.
|
$60.87M |
$3.82
-1.80%
|
|
Mister Meds and RxCompound operate as pharmaceutical contract manufacturing capabilities (compounding).
|
$52.85M |
$0.18
-3.80%
|
|
BioKey provides Contract Manufacturing Organization (CDMO) services including API characterization, formulation development, regulatory submissions, and manufacturing of clinical trial materials.
|
$50.99M |
$3.04
-7.03%
|
|
Provides contract manufacturing services to third parties, including manufacturing for external clients.
|
$49.10M |
$2.05
-3.76%
|
|
Life Sciences segment includes custom manufacturing (adenovirus production) services consistent with a CMOs.
|
$42.72M |
$36.01
|
|
PluriCDMO provides cell therapy manufacturing services (CDMO) from preclinical to commercialization.
|
$34.35M |
$4.39
-2.55%
|
|
Potential contract manufacturing/white-label services for formulations; aligns with Contract Manufacturing Organizations.
|
$33.48M |
$0.40
-4.29%
|
|
In-house contract manufacturing capabilities via Cana Laboratories Cyprus (and DolCas) underpin higher-margin manufacturing revenue.
|
$30.76M |
$1.07
-8.15%
|
|
Starco acquiring The Starco Group creates a direct Contract Manufacturing capability, aligning with Contract Manufacturing Organizations.
|
$23.53M |
$0.03
+0.83%
|
|
NXGEL's revenue is driven by contract manufacturing, including their SilverSeal products and packaging capabilities.
|
$19.67M |
$2.57
-3.02%
|
|
The company leverages contract manufacturing through 503B outsourcing facilities to produce its proprietary topical sildenafil cream and other products, fitting Contract Manufacturing Organizations as a core capability.
|
$18.76M |
$2.12
-4.93%
|
|
Core business is private-label contract manufacturing of vitamins, minerals, herbal and other health care products for global customers.
|
$16.44M |
$2.66
-3.28%
|
|
Company expanding and monetizing contract manufacturing operations (CDMO) related to its cell therapy programs.
|
$12.20M |
$0.81
-7.66%
|
|
Gelteq oversees manufacturing of its gel-based delivery systems and relies on CMOs with a dedicated facility, a core contract manufacturing service.
|
$10.55M |
$1.30
-2.99%
|
|
Chemrex is transitioning to a biotechnology-focused Contract Development and Manufacturing Organization (CDMO) model.
|
$9.32M |
$5.19
-3.71%
|
|
HIHO operates as an OEM/ODM contract manufacturer providing integrated manufacturing and subassembly services.
|
$7.35M |
$1.67
+1.21%
|
|
The company reports meaningful contract manufacturing demand growth, indicating it provides contract manufacturing services for diagnostics.
|
$7.20M |
$2.83
-4.07%
|
|
Genefic Infusion Rx’s compounding facility indicates outsourced/pharmaceutical manufacturing capabilities (Contract Manufacturing Organizations).
|
$6.85M |
$0.06
+23.91%
|
|
Core turnkey OEM/ODM contract manufacturing services enabling clients to outsource product development and manufacturing of biotech-nutraceutical/beauty/medical consumables.
|
$6.62M |
$0.03
|
|
Helpson operates as a pharmaceutical manufacturer, aligning with contract manufacturing organizations that produce drugs for sale.
|
$6.17M |
$1.89
-2.07%
|
|
ADMT operates as an FDA-registered contract manufacturing facility and provides contract manufacturing services.
|
$3.87M |
$0.09
+4.12%
|
|
The company is shifting toward outsourced OEM manufacturing services for health supplements.
|
$3.46M |
$0.09
|
|
LOI for a CNC machine shop suggests potential Contract Manufacturing capabilities post-acquisition.
|
$2.10M |
$5.31
-0.56%
|
|
Contract manufacturing services via Cana Laboratories (5-year Pharmex agreement).
|
$229298 |
$0.00
|
|
Provides contract manufacturing services for nutraceutical products, leveraging its FDA-certified manufacturing facilities.
|
$683 |
$0.01
-4.76%
|
Loading industry metrics...
Loading comparison data...
